AB
VERA icon

Amalgamated Bank’s Vera Therapeutics VERA Stock Holding History

Amalgamated Bank’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,746
Closed -$88K – 2773
2025
Q4 		$88K Buy
1,746
+211
+14% +$7.49K ﹤0.01% 1717
2025
Q3 		$45K Hold
1,535
– – ﹤0.01% 1874
2025
Q2 		$36K Hold
1,535
– – ﹤0.01% 1926
2025
Q1 		$37K Buy
1,535
+127
+9% +$4.08K ﹤0.01% 1871
2024
Q4 		$60K Hold
1,408
– – ﹤0.01% 1796
2024
Q3 		$62K Hold
1,408
– – ﹤0.01% 1790
2024
Q2 		$51K Buy
1,408
+54
+4% +$2.14K ﹤0.01% 1851
2024
Q1 		$58K Sell
1,354
-2,492
-65% -$88.8K ﹤0.01% 1830
2023
Q4 		$59K Sell
3,846
-343
-8% -$4.36K ﹤0.01% 2177
2023
Q3 		$57K Buy
4,189
+864
+26% +$14.8K ﹤0.01% 2203
2023
Q2 		$53K Buy
3,325
+730
+28% +$6.59K ﹤0.01% 2297
2023
Q1 		$20K Buy
2,595
+392
+18% +$3.03K ﹤0.01% 2654
2022
Q4 		$43K Hold
2,203
– – ﹤0.01% 2493
2022
Q3 		$47K Buy
2,203
+46
+2% +$861 ﹤0.01% 2486
2022
Q2 		$29K Buy
2,157
+719
+50% +$12.5K ﹤0.01% 2742
2022
Q1 		$34K Buy
+1,438
New +$30.9K ﹤0.01% 2636

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amalgamated Bank's VERA Position: Q1 2026 in Review

Amalgamated Bank sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 1,746 shares — an estimated $88K sold.

Amalgamated Bank first reported a position in VERA in Q1 2022 and held it in 16 quarters. The position peaked at $88K in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Amalgamated Bank reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,746 Vera Therapeutics shares in Q1 2026, an estimated $88K.
  • Amalgamated Bank first reported a position in Vera Therapeutics in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Vera Therapeutics position peaked at $88K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.